Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy
Xiaoyun Hu,1 Wenyan Qin,1 Shanqiong Li,1 Miao He,1 Yilin Wang,1 Shu Guan,2 Haishan Zhao,1 Weifan Yao,1 Minjie Wei,1 Mingyan Liu,1 Huizhe Wu1 1Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical Univer...
Main Authors: | Hu X, Qin W, Li S, He M, Wang Y, Guan S, Zhao H, Yao W, Wei M, Liu M, Wu H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/polymorphisms-in-dna-repair-pathway-genes-and-abcg2-gene-in-advanced-c-peer-reviewed-article-CMAR |
Similar Items
-
Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
by: Xia Liao, et al.
Published: (2020-01-01) -
High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
by: Hao Shu, et al.
Published: (2021-01-01) -
Effect of <it>KRAS</it> codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
by: Reinacher-Schick Anke, et al.
Published: (2012-08-01) -
Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
by: Yuanjue SUN, et al.
Published: (2009-04-01) -
Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
by: Dorte Lisbet Nielsen, et al.
Published: (2017-09-01)